IHE ETF
iShares US Pharmaceutical ETF
IHE ETF Overview
IHE ETF (iShares US Pharmaceutical ETF) is managed by iShares by BlackRock (US) with $1.60B in net assets. IHE expense ratio is 0.37%, holding 57 positions across sectors including Health Care, Financials, Consumer Staples. Inception date: 2006-05-01.
IHE performance shows a YTD return of 25.63%. The 1-year return is 40.30% and the 5-year return is 11.18%. IHE dividend yield stands at 1.35%, paid quarterly.
IHE top holdings include Eli Lilly & Co (24.8%), Johnson & Johnson - Common (21.9%), Pfizer Inc (4.8%), Zoetis, Inc. (4.7%), Merck & Company Inc (4.6%). Go to all IHE holdings, IHE sectors, or IHE dividends.
IHE can be compared against other funds. Use IHE overlap to find shared positions, or IHE vs another fund for a side-by-side view. IHE alternatives are available via the screener, along with tax-loss harvesting opportunities.